Frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading Hospital Peshawar, Khyber Pakhtunkhwa

Zia ul Haq, Mehran khan, Ambreen Afridi, Naimat Ullah

Abstract


Objective To determine the frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading hospital Peshawar Khyber Pakhtunkhwa.

 

Methods This cross sectional study was carried out in the department of Dermatology lady reading hospital Peshawar Khyber Pakhtunkhwa from 1st February 2018 to 30th July 2018. All eligible patients who presented with chronic plaque psoriasis were enrolled in the study through consecutive non probability sampling.

 

Results In our study 99 participants were included, 60 males and 39 females with the mean age 37.76±11.10 years. Dyslipidaemia was present in 30.3% of patients with 8.1percent patients showing high triglycerides. Low Density Lipoprotein was high in 3% patients and 25.3% showed high total cholesterol.

 

Conclusion Patients with plaque psoriasis may have dyslipidaemia. Chances of having dyslipidaemia in psoriatic patients increases with increased duration of disease. More robust screening techniques should be used to detect these at an early stage.

 

 

Objectives: To determine the frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading hospital Peshawar Khyber Pakhtunkhwa.

Methodology: This cross sectional study was carried out in the department of Dermatology lady reading hospital Peshawar Khyber Pakhtunkhwa from 1st February 2018 to 30th July 2018. All eligible patients who presented with chronic plaque psoriasis were enrolled in the study through consecutive non probability sampling.

Results: In our study 99 participants were included, 60 males and 39 females with the mean age 37.76 ± 11.10 years. Dyslipidaemia was present in 30.3% of patients with 8.1percent patients showing high triglycerides. Low Density Lipoprotein was high in 3% patients and 25.3% showed high total cholesterol.

Conclusion: Patients with plaque psoriasis may have dyslipidaemia. Chances of having dyslipidaemia in psoriatic patients increases with increased duration of disease. More robust screening techniques should be used to detect these at an early stage.

Objectives: To determine the frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading hospital Peshawar Khyber Pakhtunkhwa.

Methodology: This cross sectional study was carried out in the department of Dermatology lady reading hospital Peshawar Khyber Pakhtunkhwa from 1st February 2018 to 30th July 2018. All eligible patients who presented with chronic plaque psoriasis were enrolled in the study through consecutive non probability sampling.

Results: In our study 99 participants were included, 60 males and 39 females with the mean age 37.76 ± 11.10 years. Dyslipidaemia was present in 30.3% of patients with 8.1percent patients showing high triglycerides. Low Density Lipoprotein was high in 3% patients and 25.3% showed high total cholesterol.

Conclusion: Patients with plaque psoriasis may have dyslipidaemia. Chances of having dyslipidaemia in psoriatic patients increases with increased duration of disease. More robust screening techniques should be used to detect these at an early stage.

Objectives: To determine the frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading hospital Peshawar Khyber Pakhtunkhwa.

Methodology: This cross sectional study was carried out in the department of Dermatology lady reading hospital Peshawar Khyber Pakhtunkhwa from 1st February 2018 to 30th July 2018. All eligible patients who presented with chronic plaque psoriasis were enrolled in the study through consecutive non probability sampling.

Results: In our study 99 participants were included, 60 males and 39 females with the mean age 37.76 ± 11.10 years. Dyslipidaemia was present in 30.3% of patients with 8.1percent patients showing high triglycerides. Low Density Lipoprotein was high in 3% patients and 25.3% showed high total cholesterol.

Conclusion: Patients with plaque psoriasis may have dyslipidaemia. Chances of having dyslipidaemia in psoriatic patients increases with increased duration of disease. More robust screening techniques should be used to detect these at an early stage.

Objectives: To determine the frequency of dyslipidaemia in patients with plaque psoriasis in Lady Reading hospital Peshawar Khyber Pakhtunkhwa.
Methodology: This cross sectional study was carried out in the department of Dermatology lady reading hospital Peshawar Khyber Pakhtunkhwa from 1st February 2018 to 30th July 2018. All eligible patients who presented with chronic plaque psoriasis were enrolled in the study through consecutive non probability sampling.
Results: In our study 99 participants were included, 60 males and 39 females with the mean age 37.76 ± 11.10 years. Dyslipidaemia was present in 30.3% of patients with 8.1percent patients showing high triglycerides. Low Density Lipoprotein was high in 3% patients and 25.3% showed high total cholesterol.
Conclusion: Patients with plaque psoriasis may have dyslipidaemia. Chances of having dyslipidaemia in psoriatic patients increases with increased duration of disease. More robust screening techniques should be used to detect these at an early stage.

XMultiCopyPasteTime to upgrade, it’s free!Simply click on the top left of the extension and register to get access to 10 shortcuts. Your email will remain secure, but we might get in touch for your feedback! XMultiCopyPasteTime to upgrade, it’s free!Simply click on the top left of the extension and register to get access to 10 shortcuts. Your email will remain secure, but we might get in touch for your feedback! XMultiCopyPasteTime to upgrade, it’s free!Simply click on the top left of the extension and register to get access to 10 shortcuts. Your email will remain secure, but we might get in touch for your feedback! XMultiCopyPasteTime to upgrade, it’s free!Simply click on the top left of the extension and register to get access to 10 shortcuts. Your email will remain secure, but we might get in touch for your feedback!

Full Text:

PDF

References


Ahmad I, Nasreen S. Frequency and pattern of nail changes in patients with psoriasis vulgaris. J Pak Assoc Dermatol. 2009;19:149-9.

Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: diseases specific and non-diseases specific risk factors. Semin Thromb Haemostat. 2009;35:313-24.

Ali ME, Matiurrahman GM, Akhtar N, Wahab MA, Rashid MM, Islam AZMM. Efficacy and safety of leflunamaide in the treatment of plaque type psoriasis. J Pak Assoc Dermatol. 2009;19:18-22.

Glickman FS. Lepra, Psora, Psoriasis. J Am Acad Dermatol. 1986;14:863-6.

Mashhood A, Imran A. Pathogenesis of psoriasis. J Pak Assoc Dermatol. 2005;15(1):42-54.

Naldi, L, Grifiths CEM, Traditional therapies in management of chronic plaque psoriasis. Br J Dermatol. 2005;152;597-615.

Malcolam W, Greaves MD, Gerald D, Wienstein MDN. Engl J Med. 1995;332:581-9.

Jacobson CC, Kimball AB. Rethinking the psoriasis area and severity index: The impact of area should be increased. Br J Dermatol. 2004;151:381-7.

Berard F, Nicolas JF. Phisiopathologie du psoriasis. Ann Dermatol Venereal. 2003; 130: 837-42.

Cather J, Menter A. Novel Therapies for psoriasis. Am J Clin Dermatol. 2002;3:159-73.

Christophers E, Mrowieitz U. Psoriasis In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, Katz SI, et al, editors. Dermatology in general Medicine New York: McGraw Hill, 1999.p.495-521.

Gibson LE, Perry HO. Papulosquamous eruptions and exfoliative dermatitis. In: Moschella SL, Hurley HJ, editors. Dermatology. Philadelphia: WB Saunders, 1992.p.607-51.

Ortonne JP. Psoriasis, metabolic syndrome and its components. Ann Dermatol Venereal. 2008;135:235-42.

Ayala F. Clinical aspects and comorbidities of psoriasis. J Rheumatol. 2009;83:19-20.

Gelfland JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-41.

Gisondi P, Girolomoni G. Cardio metabolic comorbidities and the approach to patients with psoriasis. Actas Dermosifiliogr. 2009;2:14-21.

Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol. 2008;7:373-7.

Velageleti RS, Massaro J, Vasan RS, Robin SJ, Kannel WB, Levy D. Relation of lipid concentrations to heart failure incidence: The Framingham heart study. Circulation. 2009;120:2345-51.

Khan NI, Naz L, Mushtaq S, Rukh L, Ali S, Hussain Z. Ischemic stroke: Prevalence of modifiable risk factors in male and female patients in Pakistan. Pak J Pharm Sci. 2009;22:62-7.

Malone DC. Association of cardio metabolic risk factors and prevalent cardiovascular events. Metabolic Syndr Relat Disord. 2009;7:585-93.

Richardson SK, Gelfland JM. Update on the natural history and systemic treatment of psoriasis. Advances in Dermatology. 2008;24:171-96.

Bowcock AM, Barker JN.Genetics of psoriasis. The potential impact on new therapies. J Am Acad Dermatol. 2003;49:51-6.

Prodanovich S, Kirsner RS, Taylor JR. Treatment of patients hospitalized for psoriasis. Dermatol Clin. 2000;18;425-35.

Owen CM, Chalmers RJG, Sullivan TO, Griffiths CEM.A systemic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol. 2000;143:15-24.

Zelickson BD, Muller SA. Generalized pustular psoriasis: a review of 63 cases. Arch Dermatol 1991;127:1339–45.

Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption. Arch Dermatol. 1999;135:1479-84.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014